Antisense and RNAi Therapeutics Market: Advancing Precision Medicine Through 2034
Growing investment in nucleic acid-based drug development is supporting innovation in antisense and RNAi therapeutics. Pharmaceutical and biotechnology companies are exploring these approaches for conditions where conventional small-molecule therapies may not adequately address specific molecular targets. The Antisense and RNAi Therapeutics Market is emerging as a significant segment of the...
0 التعليقات 0 المشاركات 6 مشاهدة 0 معاينة